Imaging Features of von Hippel–Lindau Disease
Authors:
- Rebecca S. LeungRLRebecca S. Leung
- Sona V. BiswasSBSona V. Biswas
- Mark DuncanMDMark Duncan
- Sheila RankinSRSheila Rankin
- 1 January 2008
- journal article
- review article
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 28 (1) , 65-79
Abstract
Von Hippel-Lindau (VHL) disease is a rare, autosomal dominantly inherited multisystem disorder characterized by development of a variety of benign and malignant tumors. The spectrum of clinical manifestations of the disease is broad and includes retinal and central nervous system hemangioblastomas, endolymphatic sac tumors, renal cysts and tumors, pancreatic cysts and tumors, pheochromocytomas, and epididymal cystadenomas. The most common causes of death in VHL disease patients are renal cell carcinoma and neurologic complications from cerebellar hemangioblastomas. The various manifestations can be demonstrated with different imaging modalities such as ultrasonography, computed tomography, magnetic resonance imaging, and nuclear medicine. Although genetic testing is available, the manifestations of the syndrome are protean; therefore, imaging plays a key role in identification of abnormalities and subsequent follow-up of lesions. It is also used for screening of asymptomatic gene carriers and their long-term surveillance. Screening is important because the lesions in VHL disease are treatable; thus, early detection allows use of more conservative therapy and may enhance the patient's length and quality of life. A multidisciplinary team approach is important in screening for VHL disease.Keywords
This publication has 28 references indexed in Scilit:
- Spectrum of Abdominal Imaging Findings in von Hippel-Lindau DiseaseAmerican Journal of Roentgenology, 2003
- Hemangioblastomas of the Central Nervous System in von Hippel-Lindau Syndrome and Sporadic DiseaseNeurosurgery, 2001
- Von Hippel-Lindau SyndromeCancer, 1999
- Von Hippel-Lindau disease: strategies in early detection (renal-, adrenal-, pancreatic masses)European Radiology, 1999
- von Hippel-Lindau disease: genetic, clinical, and imaging features.Radiology, 1995
- Von hippel-lindau disease: New strategies in early detection and treatmentThe American Journal of Medicine, 1994
- Identification of the von Hippel-Lindau Disease Tumor Suppressor GeneScience, 1993
- Radiologic Screening for von Hippel-Lindau DiseaseJournal of Computer Assisted Tomography, 1989
- Von Hippel–Lindau disease maps to the region of chromosome 3 associated with renal cell carcinomaNature, 1988
- Lindau's diseaseThe American Journal of Medicine, 1964